Skip to main content
. 2022 Jul 14;108(23):1873–1880. doi: 10.1136/heartjnl-2022-321196

Figure 2.

Figure 2

Primary safety outcome of a composite of stroke/transient ischaemic attack, all-cause death and adverse events related to rhythm control therapy of participants receiving either early rhythm control or usual care in the overall cohort (A) and a propensity-score matched analysis (B). The HRs and the 95% CIs are presented for the composite safety outcome and for its components.